Scarica l'app Stockscreener
33.86
0.65%
0.22
Dopo l'orario di chiusura:
33.97
0.11
+0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$33.64
Aprire:
$33.76
Volume 24 ore:
2.78M
Relative Volume:
0.73
Capitalizzazione di mercato:
$14.67B
Reddito:
$2.27B
Utile/perdita netta:
$1.15B
Rapporto P/E:
13.28
EPS:
2.55
Flusso di cassa netto:
$2.80B
1 W Prestazione:
+0.18%
1M Prestazione:
+8.08%
6M Prestazione:
+17.24%
1 anno Prestazione:
+13.13%
Intervallo 1D:
$33.69
$34.10
Intervallo di 1 settimana:
$32.92
$34.12
Portata 52W:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
33.86 | 14.67B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.11B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 74.87B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.83B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 26.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Marathon Asset Management Ltd Sells 46,981 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
53,542 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by SBI Securities Co. Ltd. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Los Angeles Capital Management LLC Sells 346,803 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $3.23 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Holdings Boosted by Illinois Municipal Retirement Fund - MarketBeat
New York State Common Retirement Fund Has $6.81 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month HighHere's What Happened - MarketBeat
Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference - The Manila Times
What Will Royalty Pharma Reveal at TD Cowen's Healthcare Conference Next Week? - StockTitan
Royalty Pharma plcOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire
8,998 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by Vontobel Holding Ltd. - MarketBeat
ING Groep NV Invests $2.92 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Handelsbanken Fonder AB Has $11.74 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at $33.71 amid growth - Investing.com Australia
Peering Into Royalty Pharma's Recent Short Interest - Benzinga
Bryn Mawr Capital Management LLC Purchases 47,964 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's Why - MarketBeat
Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025 - Insider Monkey
10 Best Performing Pharma Stocks So Far in 2025 - Insider Monkey
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Baillie Gifford & Co. Sells 1,987,975 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Van ECK Associates Corp Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Ex-Dividend Reminder: Royalty Pharma, Piedmont Office Realty Trust and Western Asset Diversified Income - Nasdaq
2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street - The Globe and Mail
(RPRX) Trading Signals - Stock Traders Daily
Royalty Pharma (RPRX) to Release Quarterly Earnings on Thursday - MarketBeat
Sumitomo Mitsui Trust Group Inc. Reduces Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
abrdn plc Sells 14,685 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat
Royalty Pharma’s Internalization Strategy: Navigating Risks and Uncertainties Ahead of 2025 Transition - MSN
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Royalty Pharma's Strong Portfolio Growth and Manager Acquisition Boost Long-Term Outlook - Morningstar
Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts - MSN
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
7.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):